# VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

> **NCT02371447** · PHASE1,PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 39 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** VPM1002BC

## Key facts

- **NCT ID:** NCT02371447
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-08
- **Primary completion:** 2019-10-22
- **Final completion:** 2023-03-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371447, "VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02371447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*